The incidence of cancer of the female genital organs is extremely high. Conservative estimates place the total at more than 20 per cent of all cancer. The uterus and mammary glands seem especially vulnerable. Normally these organs are subject to (1) spurts of growth which (2) prepare them for funtion after which they (3) undergo retrogression. This generalization applies to both nonpregnant animals during estrous or menstrual cydes and to pregnant and lactating animals, the times of specific phases varying greatly in different conditions and species. These phases of growth, function, and retrogression are regulated by flood and ebb tides of ovarian and associated hormones.
mouse is transformed into (4) the actively contracting, estrous uterus (5) filled with secretion and similar to that of the normal animal at times of mating.
During this time the wall of the vagina grows so rapidly that a 2 or 3 layered epithelium is replaced by one 12 to 15 cell layers in thickness. The mammary glands grow also, but more slowly than the uterus and vagina, a longer period of estrogenic stimulation being required for full growth.1' Among the varied reactions to estrogenic hormones, the most significant one is stimulation of growth of the female genital organs.
After normal reactions had been produced by injecting moderate amounts of ovarian hormones, quantitative aspects of hormone stimulation were studied extensively. The least amount of estrogen to produce complete vaginal growth in the rat in 2 days was used as a standard unit for measurement.3 Then menstrual cydes were produced experimentally in ovariectomized adult monkeys by injection of a total of 100 rat units of estrogenic hormone in ten days.1 The mammary rudiments of the immature male monkey were grown to the equivalent of the adult non-pregnant female, but it required six months of estrogenic treatment and thousands of units of hormone. '6 Then the effects on the uterus of estrogens combined Qr in succession with the second ovarian hormone, progesterone, were worked out. 6 18, 26 Synergism between these two hormones (and in some respects, antagonism) was described. Recently the quantitative aspects of hormone balance have been extensively studied.4
With these endocrine reactions as a background, our group has turned to the study of the possibilities of inducing abnormal or atypical growths in female genital organs by long-continued stimulation with massive doses of estrogenic hormones. The first stimulus in this direction came from attendance at a lecture on the early diagnosis of cervical cancer where slides of epithelium were shown from a case in which leucoplakia had been observed. It was pointed out that this might be an early precancerous change. Similar conditions had been obtained in our experiments with ovariectomized monkeys injected with follicular hormone.1 So more extensive experiments were planned to subject monkeys to extreme estrogenic stimulation continuously,-with no respite for retrogression, as occurs normally, -and conditions were induced experimentally which closely simulated early cervical carcinoma.24 There was marked epithelial over-growth, metaplasia of the mucous glands of the cervix and, when the cervix was traumatized, penetrating epithelial infiltrations into the underlying connective tissue. But these growths retrogressed when hormonal stimulation was stopped. They did not have the ability to grow independently. This work was considered suggestive but not decisive. We now know that the estrogenic hormone then available was not sufficiently concentrated for production of excessive atypical growths.
As more potent estrogenic preparations were produced, mammary cancer was reported in male mice feminized by estrogens.20 It had been known that removal of ovaries from young mice prevented the development of mammary cancer2' by depriving them of the ovarian hormones necessary for growth of the mammary glands. As concentrated estrogenic hormones became available for experimental use, this problem was studied intensively.'4' ' Mice are ideal experimental animals for such a study.27 They have five pairs of mammary glands, the anterior ones extending up around the neck like a lady's fur and the caudal ones extending down to the base of the tail,-an extreme amount of mammary tissue.
The method of preparing these glands for study" is to slit the skin in the mid-dorsal line, remove it completely, pin it fur down to sheet cork, fix in Bouin's solution, dissect off all the glands in their enveloping fascia, stain in dilute hemalum, clear, dissect off excess connective tissue under binocular magnification, and mount all ten glands from each animal. If desired, small pieces may be excised for microscopic section, but it is remarkable how much detail can be observed in the whole mounts with low and medium powers of the compound microscope.
Using this technic, study of ten inbred strains of mice with varying susceptibilities to mammary cancer at representative ages throughout life was completed. This study established the background of control observations.
At the same time injections of estrogens were begun in male mice of several strains at minimal doses for normal growth of the mammary duct system. Although a few atypical nodular mammary growths were observed following this "feminization" of the males, no cancers appeared,1' as previously described by Lacassagne.20 The treatment was apparently at a level subthreshold for cancer. With increased doses the mammary cancers began to appear, until now a total of approximately 75 cases of cancer in "feminized" male mice have been observed. These occurred with treatment starting at birth or up to 1 20 days thereafter, and with doses ranging from 1 00 to 1000 i.u. per week.7 8 The time of appearance of the cancers ranged from 136 to more than 500 days of age. These mammary cancers in males on estrogenic treatment are transplantable and continue to grow in both female and male hosts without continuing estrogenic treatment of the hosts. Mammary cancers have been obtained in low as well as in high cancer strains of mice, but not yet in the very low cancer strain. Another point of interest is that there is apparently an optimum dose for mammary cancer; -everal times that which will induce normal growth is still below the cancer threshold, the optimum dose for mammary cancer in the mice in these experiments was 300 to 500 i.u. weekly, and greater doses (1,000 i.u. weekly) have not been followed by cancer.4 This work confirmed and extended Lacassagne's report and left no doubt of the importance of estrogenic hormone as one necessary factor in mammary carcinogenesis.
Attention was then turned to the guinea-pig, for frequently a change of experimental animal will bring to light some new viewpoint. Guinea-pigs were injected with 50 rat units of estrogen daily for periods up to 8 months. 23 The first symptom of abnormal reaction toward the end of treatment was bleeding from the vagina. In some cases this was severe enough to lead to anemia and death. The uterus on section showed a condition of extreme cystic hyperplasia and endometrial hemorrhage. Button-like fibromyomas, usually multiple, were present on the peritoneal surface of the uterus. These represent the first experimentally produced fibromyomas of the uterus. They have not appeared as yet in other animals (mice, rats, dogs, and monkeys) on similar treatment. This may be explainable on the basis of differential species susceptibility,-similar, for instance, to the incidence of fibromas of the uterus in negroes which is extremely high while in whites it is relatively low.
Turning again to the mouse as experimental animal,-it has recently been possible experimentally to meet the usual requisites for cervical carcinoma. Eighteen tumors which are histologically cervical carcinomas have been obtained in mice on long-continued estrogenic treatment. They grow rapidly, may infiltrate the musde of the rectum and neck of the bladder, and metastasize to adjacent lymph nodes. The final test of malignancy has been a demonstration of their transplantability to both male and female hosts, which survive from 6 to 8 weeks. These transplants have now been passed through four generations of hosts without continuing estrogenic treatment of the host. They are therefore truly carcinomas. 10 It is of interest to note that cervical carcinoma No. 18 appeared prolapsing from the vagina only after mammary cancers had twice been removed from this animal,--in other words, the mammary cancer appears before the cervical cancer, and must be removed to allow time for development of the latter.
There are several other effects of long-continued estrogenic treatment which are now being studied intensively and which may be classed as atypical growths, although not classifiable as cancer. The first of these is an extensive metaplasia of the epithelium of the uterine cornua in mice. It is possible by injecting estrogens in high doses, starting at very early ages when the uterus is infantile, to induce proliferation of a several layered stratified epithelium which completely replaces the single layered columnar epithelium of the endometrium of the normal animal. If injections are begun in older animals, cystic hyperplasia of the endometrium develops, and then pyometra, sometimes severe enough to be fatal. At first it was thought that this pyometra was an accentuation of the leukocytic infiltration which occurs during the retrogressive phase of the normal estrous cycle, but later it was shown to be due to invasion of the uterus by bacteria.28 When one horn of the uterus of a mouse is transplanted subcutaneously at an early age, and then the animal is given intensive estrogenic treatment, pyometra develops in the normally placed horn but not in the transplanted one which is not open to infection from the outside. It has since been found that chronic pyometra in old dogs quickly subsides after ovariectomy. The interpretation of these experiments at present is that continued intensive estrogenic stimulation may render the uterus susceptible to infection.
The estrogenic hormone's domination over growth of genital tissues, especially the epithelium, has been emphasized. It also produces marked changes in bone. As the female pocket-gopher approaches puberty the symphysis pubis is resorbed, leaving only a ligamentous connection and enlarging the pelvic outlet.'7 A similar enlargement of the birth canal occurs in mice,-not at puberty, but toward the end of the first pregnancy, and becomes more prominent with successive pregnancies. This effect can be produced experimentally in male mice by injecting estrogenic hormone.9 While pelvic bone is being resorbed, new osseous tissue is being laid down in the marrow cavities of the long bones, until in extreme cases some of them may become solidly filled with new bone."2 With perception sharpened by these experimental results, search of marrow cavities in normal pregnant mice revealed new spicules of bone forming late in gestation,-a new observation. Addition of androgen to the effective dose of estrogen prevents the reaction."3
As though obliteration of the marrow cavities had driven out blood-forming tissue, leukemia appeared in these mice under estrogenic treatment.7 (Whether the two conditions are related is unknown.) Lymphatic leukemia, malignant and transplantable, first as local tumor, then becoming systemic, is now being studied intensively."9
It must be made clear that ovarian hormones are obviously x'tot the only cause of female genital cancer,-that estrogens normally are very important growth stimulators of female genital tissues and, acting in high concentration, continuously, may produce decidedly atypical growths and are a determining factor in mammary and uterine cancer. 
